BILL · 2007–08 SESSION
HB 2659: Prescription drugs
Establishing requirements for prescription drug marketing and disclosure.
Summary
- Provides that the purpose of this act is to regulate gifts, grants, and gratuities made by pharmaceutical manufacturing companies, directly or indirectly, to any person or entity authorized to prescribe, dispense, or purchase prescription drugs in Washington.
From the Bill Digest (HB 2659), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 15, 2008
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Tami Green (D-28)
- Introduced
- January 15, 2008 in the House
- Last action
- January 15, 2008
AN ACT Relating to prescription drug marketing and disclosure;
Sponsors
Prime sponsor: Tami Green (D-28)
13 co-sponsors (13 Democrats, 0 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Health Care & Wellness.
HB 2659 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 2659 (2025–26) Commercial shellfish fees
- HB 2659 (2019–20) Vehicle taxes & fees
- HB 2659 (2017–18) Early child ed & assist prog
- HB 2659 (2015–16) Traffic fines consolidation
- HB 2659 (2013–14) Restraint of sale by trustee
- HB 2659 (2011–12) Transportation benefit dists
- HB 2659 (2009–10) Timber purchase reporting
- HB 2659 (2005–06) Small water impoundments